• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Baxter International

Baxter International

Baxter International Inc BAX 4 Star

Last Price$37.70Day Change (%)0.16%
Open Price$37.60Day Change ($)0.06
Day Range37.50–37.9052-Week Range34.77–41.94

As of Mon 7/27/2015 7:15:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Baxter International Second Quarter 2015 Financial Results Conference Call

    Baxter International Second Quarter 2015 Financial Results Conference Call

  2. Research and Markets: Ventricular Fibrillation - Global Clinical Trials Review, H1, 2015

    Research and Markets: Ventricular Fibrillation - Global Clinical Trials Review, H1, 2015

  3. Baxter Announces Pricing of Debt Tender Offers

    Baxter Announces Pricing of Debt Tender Offers

  4. Sales of Bonds With Floating Rates Sink

    Sales of Bonds With Floating Rates Sink

  5. Research and Markets: Biopharmaceuticals - Global Strategic Business Report 2015: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines

    Research and Markets: Biopharmaceuticals - Global Strategic Business Report 2015: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines

  6. Allergan to Acquire Naurex

    Allergan to Acquire Naurex

  7. Research and Markets: Catheter Stabilization Device/Catheter Securement Devices Market by Product, Application, End User - Global Forecast to 2020

    Research and Markets: Catheter Stabilization Device/Catheter Securement Devices Market by Product, Application, End User - Global Forecast to 2020

  8. Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

    Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

  9. Baxter's Spin-Off Strategy Is Promising

    Although 2015 may be rocky, both Baxter and Baxalta should see significant margin expansion and growth in the long term, says Morningstar's Karen Andersen.

  10. Health Care: A Few Stocks Still Offer Upside

    Despite the sector looking slightly overvalued, we still see stocks with attractive valuations across the different industries.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.